Ketamine Nasal Spray Provides A New Approach To Treatment Resistant Depression: New York Times March 5 2019
Of the 16 million American adults who live with depression, as many as one-quarter gain little or no benefit from available treatments, whether drugs or talk therapy. They represent perhaps the greatest unmet need in psychiatry.A newly approved treatment, called esketamine, is a nasal spray developed by Janssen Pharmaceuticals Inc., a branch of Johnson & […] Read More
Discovery Of New Drugs For Depression:
In experiments with mice, researchers at Johns Hopkins Medicine report a promising advance in the search for a new class of drugs to treat major depression. Read More
Targeted EEG Measurements To Predict Treatment Outcomes In Depression:
Key Points Of The Study: Question Does increased pretreatment rostral anterior cingulate cortex theta activity have incremental predictive validity with respect to treatment outcome in major depression? Findings In a randomized clinical trial including 296 patients with major depressive disorder, higher rostral anterior cingulate cortex theta activity at both baseline and week 1 predicted greater improvement in […] Read More
STUDENT MENTAL HEALTH IN THE ATLANTIC PROVINCES IS IN CRISIS
Students in Colleges or Universities in Atlantic Canada are confronting mental health crises on a daily basis. The students entering now are younger and seem to lack psychological resilience. This lack of resilience is resulting in an increased number of students seeking mental health support for depression, anxiety and drug addiction. Unfortunately, the system is […] Read More
THE SYSTEM FOR PROVIDING MENTAL HEALTH CARE IS BROKEN:
The system is broken- big time. That premise is proven each time a seriously ill patient does not receive care or receives inadequate or inappropriate care. Here are a few case studies that provide the evidence. case study 1: A 26 year old schizophrenic decided to stop taking his medications. He was lost to followup. […] Read More